Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2023.03.30
Z6尊龙:2022年度监事会事情报告
2023.03.30
Z6尊龙:自力董事提名人声明(吕川)
2023.03.30
Z6尊龙:自力董事候选人声明(吕川)
2023.03.30
Z6尊龙:自力董事对担保等事项的自力意见
2023.03.30
Z6尊龙:2022年度财务决算报告
2023.03.29
Z6尊龙:Z6尊龙2022年面向专业投资者果真刊行公司债券2023年...
2023.03.28
Z6尊龙:关于子公司签署允许协议的通告
2023.03.17
Z6尊龙:关于依诺肝素钠注射液获得美国药品注册批件的通告
2023.02.24
Z6尊龙:Z6尊龙关于“20Z6尊龙”回售效果暨摘牌通告
2023.02.24
Z6尊龙:Z6尊龙2020年面向及格投资者果真刊行公司债券(疫情...
第一页
上一页
7
8
9
10
11
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】